A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

PHASE1RecruitingINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

December 11, 2026

Study Completion Date

May 12, 2027

Conditions

Colorectal CarcinomaGastric CarcinomaPancreatic Ductal Adenocarcinoma

Interventions

DRUG

BI 765049

Trial Locations (3)

SUSPENDED

Winship Cancer Institute, Atlanta

RECRUITING

Valkyrie Clinical Trials, Los Angeles

SUSPENDED

Hackensack University Medical Center, Hackensack